Directed arginine deiminase evolution for efficient inhibition of arginine-auxotrophic melanomas

[1]  Ulrich Schwaneberg,et al.  To get what we aim for – progress in diversity generation methods , 2013, The FEBS journal.

[2]  Ronny Martínez,et al.  Increasing activity and thermal resistance of Bacillus gibsonii alkaline protease (BgAP) by directed evolution , 2013, Biotechnology and bioengineering.

[3]  T. Crook,et al.  Epigenetic status of argininosuccinate synthetase and argininosuccinate lyase modulates autophagy and cell death in glioblastoma , 2013, Cell Death and Disease.

[4]  J. Wolchok,et al.  Phase I/II study of pegylated arginine deiminase (ADI-PEG 20) in patients with advanced melanoma , 2013, Investigational New Drugs.

[5]  E. Querol,et al.  Structural Characterization of the Enzymes Composing the Arginine Deiminase Pathway in Mycoplasma penetrans , 2012, PloS one.

[6]  Judit Zsuga,et al.  The Hill equation and the origin of quantitative pharmacology , 2012 .

[7]  Ronny Martínez,et al.  Fluorescent Assay for Directed Evolution of Perhydrolases , 2012, Journal of biomolecular screening.

[8]  L. Old,et al.  Arginine deiminase PEG20 inhibits growth of small cell lung cancers lacking expression of argininosuccinate synthetase , 2011, British Journal of Cancer.

[9]  Jan Marienhagen,et al.  SeSaM‐Tv‐II Generates a Protein Sequence Space that is Unobtainable by epPCR , 2011, Chembiochem : a European journal of chemical biology.

[10]  Jan Marienhagen,et al.  Phosphorothioate-based ligase-independent gene cloning (PLICing): An enzyme-free and sequence-independent cloning method. , 2010, Analytical biochemistry.

[11]  Y. Ni,et al.  A Potential Antitumor Drug (Arginine Deiminase) Reengineered for Efficient Operation under Physiological Conditions , 2010, Chembiochem : a European journal of chemical biology.

[12]  F. Izzo,et al.  Phase II study of pegylated arginine deiminase for nonresectable and metastatic hepatocellular carcinoma. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  Y. Ni,et al.  Directed Evolution of an Antitumor Drug (Arginine Deiminase PpADI) for Increased Activity at Physiological pH , 2010, Chembiochem : a European journal of chemical biology.

[14]  Frank Y. S. Chuang,et al.  Arginine deiminase as a novel therapy for prostate cancer induces autophagy and caspase-independent apoptosis. , 2009, Cancer research.

[15]  Y. Ni,et al.  Arginine deiminase, a potential anti-tumor drug. , 2008, Cancer letters.

[16]  H. Lee,et al.  Expression, purification, and characterization of arginine deiminase from Lactococcus lactis ssp. lactis ATCC 7962 in Escherichia coli BL21. , 2007, Protein expression and purification.

[17]  Y. Leung,et al.  Pegylated recombinant human arginase (rhArg-peg5,000mw) inhibits the in vitro and in vivo proliferation of human hepatocellular carcinoma through arginine depletion. , 2007, Cancer research.

[18]  Li-Jiuan Shen,et al.  Drug evaluation: ADI-PEG-20--a PEGylated arginine deiminase for arginine-auxotrophic cancers. , 2006, Current opinion in molecular therapeutics.

[19]  O. Herzberg,et al.  Crystal Structures Representing the Michaelis Complex and the Thiouronium Reaction Intermediate of Pseudomonas aeruginosa Arginine Deiminase* , 2005, Journal of Biological Chemistry.

[20]  François Stricher,et al.  The FoldX web server: an online force field , 2005, Nucleic Acids Res..

[21]  F. Studier,et al.  Protein production by auto-induction in high density shaking cultures. , 2005, Protein expression and purification.

[22]  O. Herzberg,et al.  Structural Insight into Arginine Degradation by Arginine Deiminase, an Antibacterial and Parasite Drug Target* , 2004, Journal of Biological Chemistry.

[23]  A. D. Clark,et al.  Crystal structures of arginine deiminase with covalent reaction intermediates; implications for catalytic mechanism. , 2004, Structure.

[24]  F. González-Candelas,et al.  Evolution of arginine deiminase (ADI) pathway genes. , 2002, Molecular phylogenetics and evolution.

[25]  Kentaro Miyazaki,et al.  Creating random mutagenesis libraries using megaprimer PCR of whole plasmid. , 2002, BioTechniques.

[26]  J. Bomalaski,et al.  Pegylated arginine deiminase (ADI-SS PEG20,000 mw) inhibits human melanomas and hepatocellular carcinomas in vitro and in vivo. , 2002, Cancer research.

[27]  F. Zölzer,et al.  Arginine deiminase inhibits proliferation of human leukemia cells more potently than asparaginase by inducing cell cycle arrest and apoptosis , 2000, Leukemia.

[28]  F. Zölzer,et al.  Arginine deiminase inhibits cell proliferation by arresting cell cycle and inducing apoptosis. , 1999, Biochemical and biophysical research communications.

[29]  R. Daniel,et al.  L-glutamate dehydrogenases: distribution, properties and mechanism. , 1993, Comparative biochemistry and physiology. B, Comparative biochemistry.

[30]  J. Weickmann,et al.  Arginine deiminase from Mycoplasma arthritidis. Evidence for multiple forms. , 1977, The Journal of biological chemistry.

[31]  R. Archibald.  DETERMINATION OF CITRULLINE AND ALLANTOIN AND DEMONSTRATION OF CITRULLINE IN BLOOD PLASMA , 1944 .